These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
159 related articles for article (PubMed ID: 39339421)
1. Preparation, Evaluation, and Bioinformatics Study of Hyaluronic Acid-Modified Ginsenoside Rb1 Self-Assembled Nanoparticles for Treating Cardiovascular Diseases. Du L; Xiao Y; Wei Q; Guo Z; Li Y Molecules; 2024 Sep; 29(18):. PubMed ID: 39339421 [TBL] [Abstract][Full Text] [Related]
2. Preparation, characterization and in vivo pharmacokinetic study of ginsenoside Rb1-PLGA nanoparticles. Du L; Lu H; Xiao Y; Guo Z; Li Y Sci Rep; 2023 Oct; 13(1):18472. PubMed ID: 37891245 [TBL] [Abstract][Full Text] [Related]
3. Taurine loaded chitosan-pectin nanoparticle shows curative effect against acetic acid-induced colitis in rats. Ahmed O; Abdel-Halim M; Farid A; Elamir A Chem Biol Interact; 2022 Jan; 351():109715. PubMed ID: 34695389 [TBL] [Abstract][Full Text] [Related]
4. In situ preparation of water-soluble ginsenoside Rh2-entrapped bovine serum albumin nanoparticles: in vitro cytocompatibility studies. Singh P; Kim YJ; Singh H; Ahn S; Castro-Aceituno V; Yang DC Int J Nanomedicine; 2017; 12():4073-4084. PubMed ID: 28603419 [TBL] [Abstract][Full Text] [Related]
5. Preparation and characterization of antioxidant nanoparticles composed of chitosan and fucoidan for antibiotics delivery. Huang YC; Li RY Mar Drugs; 2014 Jul; 12(8):4379-98. PubMed ID: 25089950 [TBL] [Abstract][Full Text] [Related]
6. Protective Effect of Ginsenoside Rb1 Nanoparticles Against Contrast-Induced Nephropathy by Inhibiting High Mobility Group Box 1 Gene/Toll-Like Receptor 4/NF-κB Signaling Pathway. Zhou S; Lu S; Guo S; Zhao L; Han Z; Li Z J Biomed Nanotechnol; 2021 Oct; 17(10):2085-2098. PubMed ID: 34706808 [TBL] [Abstract][Full Text] [Related]
7. Phenolic Compounds and Ginsenosides in Ginseng Shoots and Their Antioxidant and Anti-Inflammatory Capacities in LPS-Induced RAW264.7 Mouse Macrophages. Yao F; Xue Q; Li K; Cao X; Sun L; Liu Y Int J Mol Sci; 2019 Jun; 20(12):. PubMed ID: 31212928 [TBL] [Abstract][Full Text] [Related]
8. Hyaluronic acid-modified betamethasone encapsulated polymeric nanoparticles: fabrication, characterisation, in vitro release kinetics, and dermal targeting. Pandey M; Choudhury H; Gunasegaran TAP; Nathan SS; Md S; Gorain B; Tripathy M; Hussain Z Drug Deliv Transl Res; 2019 Apr; 9(2):520-533. PubMed ID: 29488170 [TBL] [Abstract][Full Text] [Related]
9. Preparation of pH-sensitive carboxymethyl chitosan nanoparticles loaded with ginsenoside Rb1 and evaluation of drug release in vitro. An Z; Dong Y; Wang W; Wang J; Wu Z; Wang W; He Y; Bao G Int J Biol Macromol; 2024 May; 267(Pt 2):131487. PubMed ID: 38599430 [TBL] [Abstract][Full Text] [Related]
10. Intermolecular interactions between salmon calcitonin, hyaluronate, and chitosan and their impact on the process of formation and properties of peptide-loaded nanoparticles. Umerska A; Corrigan OI; Tajber L Int J Pharm; 2014 Dec; 477(1-2):102-12. PubMed ID: 25447822 [TBL] [Abstract][Full Text] [Related]
11. Evaluation of the effect of designed PLGA-arctiin nanoparticles modified with folic acid and chitosan on colon cancer cells. Alhadidi MHA; Tabrizi MH; Ghobeh M Biotechnol Appl Biochem; 2024 Feb; 71(1):72-80. PubMed ID: 37817403 [TBL] [Abstract][Full Text] [Related]
12. Hyaluronic-Coated Albumin Nanoparticles for the Non-Invasive Delivery of Apatinib in Diabetic Retinopathy. Radwan SE; El-Kamel A; Zaki EI; Burgalassi S; Zucchetti E; El-Moslemany RM Int J Nanomedicine; 2021; 16():4481-4494. PubMed ID: 34239300 [TBL] [Abstract][Full Text] [Related]
13. GE11 peptide modified and reduction-responsive hyaluronic acid-based nanoparticles induced higher efficacy of doxorubicin for breast carcinoma therapy. Hu D; Mezghrani O; Zhang L; Chen Y; Ke X; Ci T Int J Nanomedicine; 2016; 11():5125-5147. PubMed ID: 27785019 [TBL] [Abstract][Full Text] [Related]
14. Preparation, characterization and preliminary pharmacokinetic study of pH-sensitive Hydroxyapatite/Zein nano-drug delivery system for doxorubicin hydrochloride. Zha L; Wang B; Qian J; Fletcher B; Zhang C; Dong Q; Chen W; Hong L J Pharm Pharmacol; 2020 Apr; 72(4):496-506. PubMed ID: 31975457 [TBL] [Abstract][Full Text] [Related]
15. Formulated chitosan-sodium tripolyphosphate nanoparticles for co-encapsulation of ellagic acid and anti-inflammatory peptide: characterization, stability and anti-inflammatory activity. Xiong Y; Feng YX; Chang M; Wang Q; Yin SN; Jian LY; Ren DF J Sci Food Agric; 2023 May; 103(7):3447-3456. PubMed ID: 36812130 [TBL] [Abstract][Full Text] [Related]
16. CD44-specific nanoparticles for redox-triggered reactive oxygen species production and doxorubicin release. Lin CW; Lu KY; Wang SY; Sung HW; Mi FL Acta Biomater; 2016 Apr; 35():280-92. PubMed ID: 26853764 [TBL] [Abstract][Full Text] [Related]
17. Thermosensitive hydrogel with emodin-loaded triple-targeted nanoparticles for a rectal drug delivery system in the treatment of chronic non-bacterial prostatitis. Ye Y; Zhong W; Luo R; Wen H; Ma Z; Qi S; Han X; Nie W; Chang D; Xu R; Ye N; Gao F; Zhang P J Nanobiotechnology; 2024 Jan; 22(1):33. PubMed ID: 38238760 [TBL] [Abstract][Full Text] [Related]
18. Skin delivery of epigallocatechin-3-gallate (EGCG) and hyaluronic acid loaded nano-transfersomes for antioxidant and anti-aging effects in UV radiation induced skin damage. Avadhani KS; Manikkath J; Tiwari M; Chandrasekhar M; Godavarthi A; Vidya SM; Hariharapura RC; Kalthur G; Udupa N; Mutalik S Drug Deliv; 2017 Nov; 24(1):61-74. PubMed ID: 28155509 [TBL] [Abstract][Full Text] [Related]
19. Effects of ginsenoside Rb1 on spinal cord ischemia-reperfusion injury in rats. Ye JT; Li FT; Huang SL; Xue JL; Aihaiti Y; Wu H; Liu RX; Cheng B J Orthop Surg Res; 2019 Aug; 14(1):259. PubMed ID: 31412899 [TBL] [Abstract][Full Text] [Related]
20. Raloxifene-encapsulated hyaluronic acid-decorated chitosan nanoparticles selectively induce apoptosis in lung cancer cells. Almutairi FM; Abd-Rabou AA; Mohamed MS Bioorg Med Chem; 2019 Apr; 27(8):1629-1638. PubMed ID: 30879864 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]